Mengmeng Lv
- Cancer Research top 1%
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 7
- Molecular Biology top 5%
- Circular RNAs in diseases 14
- Advanced biosensing and bioanalysis techniques 10
- RNA Interference and Gene Delivery 7
- Extracellular vesicles in disease 7
- Oncology top 10%
- Reproductive Medicine top 10%
-
- Microbial Natural Products and Biosynthesis 5
-
- Endometrial and Cervical Cancer Treatments 4
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Mengmeng Lv
57 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 129
- Cancer Research 1.1k
- Molecular Biology 1.4k
- Oncology 234
- Reproductive Medicine 65
- Renewable Energy, Sustainability and the Environment 121
Countries citing papers authored by Mengmeng Lv
This map shows the geographic impact of Mengmeng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Lv more than expected).
Fields of papers citing papers by Mengmeng Lv
This network shows the impact of papers produced by Mengmeng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Lv. The network helps show where Mengmeng Lv may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengmeng Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 26 | |
| 6 | 2021 | 9 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 43 | |
| 9 | 2017 | 32 | |
| 10 | 2016 | 29 | |
| 11 | 2015 | 55 | |
| 12 | 2015 | 58 | |
| 13 | 2014 | 47 | |
| 14 | 2014 | 127 | |
| 15 | 2014 | 9 | |
| 16 | 2014 | 10 | |
| 17 | 2014 | 21 | |
| 18 | 2014 | 24 | |
| 19 | 2013 | 53 | |
| 20 | 2013 | 51 |
About Mengmeng Lv
Mengmeng Lv is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine, having authored 58 papers that have together received 2.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (15 papers), Circular RNAs in diseases (14 papers), Advanced biosensing and bioanalysis techniques (10 papers), RNA Interference and Gene Delivery (7 papers), Cancer-related molecular mechanisms research (7 papers), Extracellular vesicles in disease (7 papers), Microbial Natural Products and Biosynthesis (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.4k citations) and Oncology (234 citations). Mengmeng Lv has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Shanliang Zhong, Jianhua Zhao, Jinhai Tang, Wei‐xian Chen, Tengfei Ma, Xingya Zhu, Qing Hu, Lin Chen, Minghua Ji and Luo Zhou. Their work appears in journals such as Nucleic Acids Research, Advanced Materials and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.